ZEISS creates a compelling new way of utilizing targeted X-ray radiotherapy to sterilize the tumor beds of resectable brain tumors and metastatic lesions in the spine. A radiation oncologist from a leading medical research facility will talk about how intraoperative radiotherapy is used in adjuvant treatment of brain tumors. Please join us in hearing from Dr. Ehsan Balagamwala on CNS radiotherapy solutions available from ZEISS.
Dr. Ehsan Balagamwala is currently on faculty in the Department of Radiation Oncology at the Cleveland Clinic Lerner College of Medicine. Dr. Balagamwala has published extensively in the field of brain and spine tumors with over 30 peer reviewed articles and over a dozen book chapters. He is currently spearheading an investigator-initiated clinical trial evaluating single fraction vs 2 fraction spine SBRT.
The statements of the speakers reflect only their personal opinions and do not necessarily reflect the opinions of any institution with which they are affiliated. The speakers have a contractual or other financial relationship with Carl Zeiss Meditec, Inc. and its affiliates and have received financial support.